These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1333478)

  • 21. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid detection of cytomegalovirus antigen on alveolar cells in bronchoalveolar fluid from transplant patients with cytomegalovirus pneumonia.
    Heurlin N; Markling L; Barkholt L; Lönnqvist B; Andersson J; Ringdén O
    Clin Transplant; 1994 Oct; 8(5):466-73. PubMed ID: 7819613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation.
    Boeckh M; Bowden RA; Goodrich JM; Pettinger M; Meyers JD
    Blood; 1992 Sep; 80(5):1358-64. PubMed ID: 1325214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: examination of a preemptive plan of ganciclovir therapy.
    Mandanas RA; Saez RA; Selby GB; Confer DL
    Am J Hematol; 1996 Feb; 51(2):104-11. PubMed ID: 8579049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A risk-adapted approach with a short course of ganciclovir to prevent cytomegalovirus (CMV) pneumonia in CMV-seropositive recipients of allogeneic bone marrow transplants.
    Verdonck LF; Dekker AW; Rozenberg-Arska M; van den Hoek MR
    Clin Infect Dis; 1997 May; 24(5):901-7. PubMed ID: 9142790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation.
    Hebart H; Müller C; Löffler J; Jahn G; Einsele H
    Bone Marrow Transplant; 1996 May; 17(5):861-8. PubMed ID: 8733710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preemptive ganciclovir administration based solely on asymptomatic pulmonary cytomegalovirus infection in allogeneic bone marrow transplant recipients: long-term follow-up.
    Zaia JA; Schmidt GM; Chao NJ; Rizk NW; Nademanee AP; Niland JC; Horak DA; Lee J; Gallez-Hawkins G; Kusnierz-Glaz CR
    Biol Blood Marrow Transplant; 1995 Dec; 1(2):88-93. PubMed ID: 9118297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study.
    Boeckh M; Gooley TA; Myerson D; Cunningham T; Schoch G; Bowden RA
    Blood; 1996 Nov; 88(10):4063-71. PubMed ID: 8916975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of cytomegalovirus pneumonitis on bronchoalveolar lavage fluid: comparison of cytology, immunofluorescence, and in situ hybridization with viral isolation.
    Weiss RL; Snow GW; Schumann GB; Hammond ME
    Diagn Cytopathol; 1991; 7(3):243-7. PubMed ID: 1652413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus infections after allogeneic bone marrow transplantation.
    Winston DJ; Ho WG; Champlin RE
    Rev Infect Dis; 1990; 12 Suppl 7():S776-92. PubMed ID: 2173107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of cytomegalovirus in bronchoalveolar lavage specimens. Spin amplification and staining with a monoclonal antibody to the early nuclear antigen for diagnosis of cytomegalovirus pneumonia.
    Woods GL; Thompson AB; Rennard SL; Linder J
    Chest; 1990 Sep; 98(3):568-75. PubMed ID: 2168309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients.
    Vlieger AM; Boland GJ; Jiwa NM; de Weger RA; Willemze R; de Gast GC; Falkenburg JH
    Bone Marrow Transplant; 1992 Apr; 9(4):247-53. PubMed ID: 1318141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid detection of cytomegalovirus pneumonia from lung lavage cells.
    Paradis IL; Grgurich WF; Dummer JS; Dekker A; Dauber JH
    Am Rev Respir Dis; 1988 Sep; 138(3):697-702. PubMed ID: 2849341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.
    Noble S; Faulds D
    Drugs; 1998 Jul; 56(1):115-46. PubMed ID: 9664203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term sequelae after recovery from cytomegalovirus pneumonia in allogeneic bone marrow transplant recipients.
    Chien SM; Chan CK; Kasupski G; Chamberlain D; Fyles G; Messner H
    Chest; 1992 Apr; 101(4):1000-4. PubMed ID: 1313348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia.
    Beam E; Germer JJ; Lahr B; Yao JDC; Limper AH; Binnicker MJ; Razonable RR
    Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29112278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin.
    Emanuel D; Cunningham I; Jules-Elysee K; Brochstein JA; Kernan NA; Laver J; Stover D; White DA; Fels A; Polsky B
    Ann Intern Med; 1988 Nov; 109(10):777-82. PubMed ID: 2847609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis.
    Nicholson VA; Whimbey E; Champlin R; Abi-Said D; Przepiorka D; Tarrand J; Chan K; Bodey GP; Goodrich JM
    Bone Marrow Transplant; 1997 Jan; 19(1):37-41. PubMed ID: 9012929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytomegalovirus detection in blood and bronchoalveolar lavage, and prophylaxis or preemptive treatment with ganciclovir in children with allogeneic stem cell transplantation].
    Figueroa C; Bonduel M; Paganini H; Botto H; Casimir L
    Enferm Infecc Microbiol Clin; 2006 Mar; 24(3):162-6. PubMed ID: 16606557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of severe cytomegalovirus infection with ganciclovir and high-dose intravenous immunoglobulin in patients with allogeneic bone marrow transplants. A pilot study.
    Lehn P; Quessar A; Devergie A; Esperou-Bourdeau H; Traineau R; Trédaniel J; Benbunan M; Bussel A; Jolivet I; Mazeron MC
    Nouv Rev Fr Hematol (1978); 1990; 32(1):17-20. PubMed ID: 2161510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.